Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 19, 2021

SELL
$657.71 - $825.77 $33.7 Million - $42.3 Million
-51,223 Closed
0 $0
Q2 2021

Jul 16, 2021

BUY
$576.64 - $649.04 $29.5 Million - $33.2 Million
51,223 New
51,223 $33 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.34B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Exane Asset Management Portfolio

Follow Exane Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Exane Asset Management with notifications on news.